Trial intelligence / Profile preview

Oral salbutamol versus placebo in adults with spinal muscular atrophy type III

2007-001088-32Phase 2Completed

Sponsor
Carlo Besta Neurological Institute
Start
Jul 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of salbutamol in spinal muscular atrophy (SMA), sponsored by Carlo Besta Neurological Institute. Started Jul 2008; status: completed.

02

Drugs

salbutamol
03

Conditions

spinal muscular atrophy (SMA)

Beyond the preview

Go deeper on 2007-001088-32.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-001088-32.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call